These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 36527486)
1. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486 [TBL] [Abstract][Full Text] [Related]
2. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. T Vicente C; Perneel J; Wynants S; Heeman B; Van den Broeck M; Baker M; Cheung S; Faura J; Mackenzie IRA; Rademakers R Brain; 2023 Oct; 146(10):4055-4064. PubMed ID: 37100087 [TBL] [Abstract][Full Text] [Related]
3. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750 [TBL] [Abstract][Full Text] [Related]
4. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency. Zhou X; Sun L; Brady OA; Murphy KA; Hu F Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008 [TBL] [Abstract][Full Text] [Related]
5. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706 [TBL] [Abstract][Full Text] [Related]
14. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111 [TBL] [Abstract][Full Text] [Related]
15. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice. Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860 [TBL] [Abstract][Full Text] [Related]
16. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration. Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901 [TBL] [Abstract][Full Text] [Related]
17. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Gallagher MD; Suh E; Grossman M; Elman L; McCluskey L; Van Swieten JC; Al-Sarraj S; Neumann M; Gelpi E; Ghetti B; Rohrer JD; Halliday G; Van Broeckhoven C; Seilhean D; Shaw PJ; Frosch MP; Alafuzoff I; Antonell A; Bogdanovic N; Brooks W; Cairns NJ; Cooper-Knock J; Cotman C; Cras P; Cruts M; De Deyn PP; DeCarli C; Dobson-Stone C; Engelborghs S; Fox N; Galasko D; Gearing M; Gijselinck I; Grafman J; Hartikainen P; Hatanpaa KJ; Highley JR; Hodges J; Hulette C; Ince PG; Jin LW; Kirby J; Kofler J; Kril J; Kwok JB; Levey A; Lieberman A; Llado A; Martin JJ; Masliah E; McDermott CJ; McKee A; McLean C; Mead S; Miller CA; Miller J; Munoz DG; Murrell J; Paulson H; Piguet O; Rossor M; Sanchez-Valle R; Sano M; Schneider J; Silbert LC; Spina S; van der Zee J; Van Langenhove T; Warren J; Wharton SB; White CL; Woltjer RL; Trojanowski JQ; Lee VM; Van Deerlin V; Chen-Plotkin AS Acta Neuropathol; 2014 Mar; 127(3):407-18. PubMed ID: 24442578 [TBL] [Abstract][Full Text] [Related]
18. TMEM106B Fibrils from FTLD Patients and Healthy Controls. Greenwood JD; Powell WC; Walczak MA ACS Chem Neurosci; 2023 Aug; 14(16):2827-2829. PubMed ID: 37530644 [TBL] [Abstract][Full Text] [Related]
19. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. Root J; Merino P; Nuckols A; Johnson M; Kukar T Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000 [TBL] [Abstract][Full Text] [Related]
20. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Chang A; Xiang X; Wang J; Lee C; Arakhamia T; Simjanoska M; Wang C; Carlomagno Y; Zhang G; Dhingra S; Thierry M; Perneel J; Heeman B; Forgrave LM; DeTure M; DeMarco ML; Cook CN; Rademakers R; Dickson DW; Petrucelli L; Stowell MHB; Mackenzie IRA; Fitzpatrick AWP Cell; 2022 Apr; 185(8):1346-1355.e15. PubMed ID: 35247328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]